Sage Journals: Discover world-class research

Open access

Research article

First published 2023

Hyperprogressive Disease (HPD) in Solid Tumours Receiving Immune Checkpoint Inhibitors in a Real-World Setting

Yada Kanjanapan, Geetha Guduguntla, Ashwati Krishnan Varikara [...]

Technology in Cancer Research & Treatment

Retricted access

Case report

First published 2020-1

Hyperprogression after nivolumab for melanoma: A case report

Mesut Yilmaz, Burak Akovali

Journal of Oncology Pharmacy Practice

Retricted access

Case report

First published 2022-12

Squamous cell histological transformation in a lung adenocarcinoma patient (hyper) progressing upon immunotherapy

Annapaola Mariniello, Luisella Righi, Antonio Morrone [...]

Tumori Journal

Open access

Review article

First published 2023

Correlation of preclinical and clinical biomarkers with efficacy and toxicity of cancer immunotherapy

Lin-Peng Zheng, Jing Yang, Xie-Wan Chen [...]

Therapeutic Advances in Medical Oncology

Open access

Case report

First published 2021

Hyperprogression in a Patient With Hepatocellular Cancer Treated With Atezolizumab and Bevacizumab: A Case Report and Review of Literature

Balraj Singh, Parminder Kaur, Michael Maroules

Journal of Investigative Medicine High Impact Case Reports

Open access

Research article

First published 2022-4

Rapid subcutaneous progression after immunotherapy in pretreated patients with metastatic carcinoma: two case reports

Yong Da, Ge Shen, Ming Zhou [...]

Journal of International Medical Research

Free access

Review article

First published 2022-1

Current Perspectives on the Immunosuppressive Niche and Role of Fibrosis in Hepatocellular Carcinoma and the Development of Antitumor Immunity

Tomoko Aoki, Naoshi Nishida, Masatoshi Kudo

Journal of Histochemistry & Cytochemistry

Search results

Hyperprogressive Disease (HPD) in Solid Tumours Receiving Immune Checkpoint Inhibitors in a Real-World Setting

Hyperprogression after nivolumab for melanoma: A case report

Squamous cell histological transformation in a lung adenocarcinoma patient (hyper) progressing upon immunotherapy

Correlation of preclinical and clinical biomarkers with efficacy and toxicity of cancer immunotherapy

Hyperprogression in a Patient With Hepatocellular Cancer Treated With Atezolizumab and Bevacizumab: A Case Report and Review of Literature

Rapid subcutaneous progression after immunotherapy in pretreated patients with metastatic carcinoma: two case reports

Current Perspectives on the Immunosuppressive Niche and Role of Fibrosis in Hepatocellular Carcinoma and the Development of Antitumor Immunity